Sartorius AG: First-Quarter Figures | Resolutions of the Annual Shareholders’ Meeting

GOETTINGEN, Germany--(BUSINESS WIRE)--At today’s Annual Shareholders' Meeting of the Sartorius technology group, CEO and Executive Board Chairman Dr. Joachim Kreuzburg presented the consolidated results for the first three months of 2010. The Biotechnology Division, which operates under the name Sartorius Stedim Biotech and contributes a good two-thirds to consolidated sales, started off the year 2010 by reporting growth and further profitability gains again. After enduring a sharp decline in its business during the year of crisis in 2009 and undergoing extensive restructuring and realignment, the Mechatronics Division also reported positive results. The division posted a significant uptick in order intake, a slight increase in sales and positive earnings. “These first-quarter business results show that both divisions developed entirely within the range of our expectations, and we confirm our positive outlook for the full year,” commented CEO Dr. Joachim Kreuzburg.

Back to news